APA (7th ed.) Citation

W, F., CP, M., C, B., JA, D., K, D., S, B., . . . KN, B. (2023). Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1. Blood cancer journal, 13(1), 53. https://doi.org/10.1038/s41408-023-00826-6

Chicago Style (17th ed.) Citation

W, Fiskus, et al. "Targeting of Epigenetic Co-dependencies Enhances Anti-AML Efficacy of Menin Inhibitor in AML with MLL1-r or Mutant NPM1." Blood Cancer Journal 13, no. 1 (2023): 53. https://doi.org/10.1038/s41408-023-00826-6.

MLA (9th ed.) Citation

W, Fiskus, et al. "Targeting of Epigenetic Co-dependencies Enhances Anti-AML Efficacy of Menin Inhibitor in AML with MLL1-r or Mutant NPM1." Blood Cancer Journal, vol. 13, no. 1, 2023, p. 53, https://doi.org/10.1038/s41408-023-00826-6.